Where does Kevin Craig work?

Kevin Craig is Chief Medical Officer at atai Life Sciences.

What does Kevin Craig invest in?

Kevin Craig invests in Biotech, Digital Health, Mental Health.

Where did Kevin Craig go to school?

Kevin Craig studied at University of Cambridge (MPhil, Medicine); Royal College of Psychiatrists (MRCPsych, Board certified in adult psychiatry and addiction); University of the Witwatersrand (Bachelor of Medicine, Bachelor of Surgery - MBBS).

Kevin Craig

Investor

Chief Medical Officer at atai Life Sciences · Chief Medical Officer at AtaiBeckley

London, England, United Kingdom

Find your path to Kevin

341 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.

Leonard PicardounlockedKevin: together at University of Cambridge (2004–2005)

×4Kevin: together at University of Cambridge

×4Kevin: together at University of the Witwatersrand

×2Kevin: together at NHS

About

Kevin Craig became Chief Medical Officer of atai Life Sciences in 2025, having joined in 2021 as Vice President and later Senior Vice President of Clinical Development, where he oversees clinical development, regulatory affairs, drug safety, biostatistics, and global clinical operations. He has more than 20 years of clinical experience with a focus on neuroscience pipelines, and previously held a faculty appointment at the University of Cambridge's Behavioral and Clinical Neuroscience Institute and worked at P1vital on imaging and cognitive biomarkers for early-phase psychiatry trials. He earned his medical degree from the University of Witwatersrand and an MPhil in Medical Science from the University of Cambridge, and is a member of the Royal College of Psychiatrists with accreditation in addiction and adult psychiatry.

Invests in

BiotechDigital HealthMental Health

Experience

AtaiBeckleyChief Medical Officercurrent2025 — presentLondon Area, United Kingdom
AtaiBeckleySVP, Clinical Development2023 — 2025London, England, United Kingdom
AtaiBeckleyVice President, Clinical Development2021 — 2023London, England, United Kingdom
Jazz PharmaceuticalsHead of Early Clinical Development2021London, England, United Kingdom
GW Pharmaceuticals plcHead of Early Clinical Development2018 — 2021London, United Kingdom
CovanceGlobal Head of Medical Science, Clinical Pharmacology2018London, United Kingdom
CovanceSenior Medical Director, Early Clinical Services2016 — 2018United Kingdom
CovanceSenior Medical Director, Neuroscience2014 — 2016Singapore
CovanceMedical Director, Neuroscience2011 — 2014Maidenhead, United Kingdom
Singapore-MIT Alliance for Research & Technology Innovation CenterAdvisory Board Member and Catalyst2014 — 2016Singapore
P1vitalChief Medical Officer2010 — 2011Oxford, United Kingdom
P1vitalMedical Director2008 — 2010
University of CambridgeSenior Clinical Research Fellow2006 — 2008Cambridge, United Kingdom
NHSPsychiatrist1999 — 2006

Skills & more

BiopharmaceuticalsInvestigational New Drug Application (IND)U.S. Food and Drug Administration (FDA)LeadershipResearch and Development (R&D)Medical Group ManagementPhase 1 patient studiesRare DiseasesCNS disordersRegulatory AffairsBiostatisticsDigital Therapeutics

+12 more

Portfolio ManagementStrategic ThinkingBusiness DevelopmentPsychiatryClinical TrialsNeuroscienceClinical ResearchClinical DevelopmentDrug DevelopmentNeuropharmacologyBiomarkersMedicine

From Kevin's professional profile.

Colleagues at atai Life Sciences

Amir Kalali

Director at atai Life Sciences

Andrea Heslin Smiley

Director at atai Life Sciences

Anne Johnson

Chief Accounting Officer at atai Life Sciences

Christian Angermayer

Founder and Chairman of the Board at atai Life Sciences

Gerd Kochendoerfer

Chief Operating Officer at atai Life Sciences

Glenn Short

Chief Scientific Officer at atai Life Sciences

John Hoffman

Director at atai Life Sciences

Laurent Fischer

Director at atai Life Sciences

Frequently asked questions

Who is Kevin Craig?: Kevin Craig became Chief Medical Officer of atai Life Sciences in 2025, having joined in 2021 as Vice President and later Senior Vice President of Clinical Development, where he oversees clinical development, regulatory affairs, drug safety, biostatistics, and global clinical operations. He has more than 20 years of clinical experience with a focus on neuroscience pipelines, and previously held a faculty appointment at the University of Cambridge's Behavioral and Clinical Neuroscience Institute and worked at P1vital on imaging and cognitive biomarkers for early-phase psychiatry trials. He earned his medical degree from the University of Witwatersrand and an MPhil in Medical Science from the University of Cambridge, and is a member of the Royal College of Psychiatrists with accreditation in addiction and adult psychiatry.
Where does Kevin Craig work?: Kevin Craig is Chief Medical Officer at atai Life Sciences.
What does Kevin Craig invest in?: Kevin Craig invests in Biotech, Digital Health, Mental Health.
Where did Kevin Craig go to school?: Kevin Craig studied at University of Cambridge (MPhil, Medicine); Royal College of Psychiatrists (MRCPsych, Board certified in adult psychiatry and addiction); University of the Witwatersrand (Bachelor of Medicine, Bachelor of Surgery - MBBS).

Same school

Also attended University of Cambridge1,413

Stewart ButterfieldCo-founder of Slack and Flickr Demis HassabisCo-founder & CEO of Google DeepMind Niko BonatsosFounder and Managing Partner of Verdict Georgia StevensonInvestor at Index Ventures Hannah SealInvestor at Index Ventures Leah von SiemensPartner at Manta Ray Ventures

+ 1,407 more

Also attended University of the Witwatersrand123

David FrankelSeed Stage Venture Capital in the United States ThomasGeneral Partner at Acadian Ventures Management, Llc Daniel SassAssociate at aMoon David EsraAnalyst at aMoon Samantha RobertsInvestor at Syncona Ilian IlievChief Executive Officer at EMV Capital

+ 117 more

Shared employers

Also worked at AtaiBeckley11

Christian zu JeddelohInvestment Manager at Norrsken VC Robert HershbergSenior Advisor at Frazier Life Sciences Srinivas RaoCo-Founder and Chief Executive Officer at atai Life Sciences Gerd KochendoerferChief Operating Officer at atai Life Sciences Anne JohnsonChief Accounting Officer at atai Life Sciences Scott BraunsteinVice-Chairman of the Board and Director at atai Life Sciences

+ 5 more

Also worked at Jazz Pharmaceuticals11

Elena VibochManaging Director at General Catalyst Denise KnoppingVP of People at Longitude Capital Patrick EnrightManaging Director at Longitude Capital Matthew YoungManaging Director at Longitude Capital Samir MalhotraInvestment Partner at Civilization Ventures Management, Llc Lawrence CarterFellow at High Street Equity Partners

+ 5 more

Also worked at Singapore-MIT Alliance for Research & Technology Innovation Center10

Vadim ShpakVenture Partner at Vickers Venture Partners Dr. Virginia ChaVenture Partner at iGlobe Partners Gerard ChiaPartner at Clay Capital Menno van der ZeeInvestor at Volve Capital Vishal HarnalGlobal Managing Partner; Managing Partner, Southeast Asia at 500 Startups Vietnam Adit AbrahamFounder at Reducto

+ 4 more

Also worked at NHS56

Francois PrinslooInvestor at Medicxi Shahzad MalikGeneral Partner at Advent Life Sciences Svetlana KingFinancial Planning and Analysis Manager at EMV Capital Elaine HegartyChief of Staff at IQ Capital Rosie BarnettPrincipal at Delin Ventures Nihal SinhaPartner at F-Prime Capital Partners

+ 50 more